Use of long-acting reversible contraceptives in the UK from 2004 to 2010: analysis using The Health Improvement Network Database

Autor:	Lucía Cea Soriano, Luis A. García Rodríguez, Mari-Ann Wallander, Susan Andersson, A. Filonenko
Rok vydání:	2014
Předmět:	Adult medicine.medical_specialty genetic structures Health improvement Adolescent Databases Factual Population Reproductive age Levonorgestrel Injections Cohort Studies Young Adult Contraceptive Agents Female Medicine Humans Pharmacology (medical) education Network model Gynecology Drug Implants education.field_of_study business.industry Intrauterine Devices Medicated Obstetrics and Gynecology medicine.disease Intrauterine Devices Copper United Kingdom Long acting Contraception Reproductive Medicine Family planning General practice Female Medical emergency Progestins business Developed country
Zdroj:	The European journal of contraceptionreproductive health care : the official journal of the European Society of Contraception. 19(6)
ISSN:	1473-0782
Popis:	To determine the use of long-acting reversible contraceptives (LARCs) in the UK over the period 2004 to 2010, using the general practice database The Health Improvement Network (THIN).Women in THIN, aged 18 to 44 years during 2004 to 2010, who had been registered with their general practitioner for at least five years, with a prescription history of at least one year were included. THIN was searched using the Read and MULTILEX codes for: copper intrauterine devices (Cu-IUDs), the levonorgestrel releasing-intrauterine system (LNG-IUS), progestogen-only implants, and progestogen-only injections.The prevalence of progestogen-only implant use rose from 0.5 to 3.4%, and that of the LNG-IUS from 3.1 to 5.2%. The annual incidence and prevalence of progestogen-only implant use increased for all age groups but was most marked in younger women, whereas the use of the LNG-IUS augmented with increasing age. For all women, there was a small decrease in the prevalence of use of Cu-IUDs (from 5.4 to 4.8%) and progestogen-only injections (from 3.6 to 3.2%).Uptake of progestogen-only implants and the LNG-IUS increased over the period 2004 to 2010 in the UK, but LARC use in young women remains low.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa599daa7e3312d63d93082348e28407 https://pubmed.ncbi.nlm.nih.gov/25139412 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.